BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32434398)

  • 1. Glucocorticoids in rheumatoid arthritis: the silent companion in the therapeutic strategy.
    Berardicurti O; Ruscitti P; Pavlych V; Conforti A; Giacomelli R; Cipriani P
    Expert Rev Clin Pharmacol; 2020 Jun; 13(6):593-604. PubMed ID: 32434398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.
    Gorter SL; Bijlsma JW; Cutolo M; Gomez-Reino J; Kouloumas M; Smolen JS; Landewé R
    Ann Rheum Dis; 2010 Jun; 69(6):1010-4. PubMed ID: 20448288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoids in rheumatoid arthritis: current status and future studies.
    Hua C; Buttgereit F; Combe B
    RMD Open; 2020 Jan; 6(1):. PubMed ID: 31958273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.
    Chatzidionysiou K; Emamikia S; Nam J; Ramiro S; Smolen J; van der Heijde D; Dougados M; Bijlsma J; Burmester G; Scholte M; van Vollenhoven R; Landewé R
    Ann Rheum Dis; 2017 Jun; 76(6):1102-1107. PubMed ID: 28356243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose corticosteroids and disease modifying drugs in patients with rheumatoid arthritis.
    Malysheva O; Baerwald CG
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S113-5. PubMed ID: 22018195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of repository corticotropin injection as an adjunctive therapy for the treatment of rheumatoid arthritis.
    Fleischmann R; Furst DE
    Expert Opin Drug Saf; 2020 Aug; 19(8):935-944. PubMed ID: 32497440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate.
    Cutolo M; Shoenfeld Y; Bogdanos DP; Gotelli E; Salvato M; Gunkl-Tóth L; Nagy G
    Autoimmun Rev; 2024 Jan; 23(1):103437. PubMed ID: 37652398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial.
    Hartman L; Rasch LA; Klausch T; Bijlsma HWJ; Christensen R; Smulders YM; Ralston SH; Buttgereit F; Cutolo M; Da Silva JAP; Opris D; Rovenský J; Szamosi S; Middelink LM; Lems WF; Boers M
    Trials; 2018 Jan; 19(1):67. PubMed ID: 29370811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid safety for treating rheumatoid arthritis.
    Rasch LA; Bultink IE; van Tuyl LH; Lems WF
    Expert Opin Drug Saf; 2015 Jun; 14(6):839-44. PubMed ID: 25802019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An updated review of glucocorticoid-related adverse events in patients with rheumatoid arthritis.
    Luís M; Freitas J; Costa F; Buttgereit F; Boers M; Jap DS; Santiago T
    Expert Opin Drug Saf; 2019 Jul; 18(7):581-590. PubMed ID: 31056959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of low-dose glucocorticoids for rheumatoid arthritis in the biologic era.
    Caporali R; Scirè CA; Todoerti M; Montecucco C
    Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S9-13. PubMed ID: 24129129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid use in rheumatoid arthritis: benefits, mechanisms, and risks.
    Townsend HB; Saag KG
    Clin Exp Rheumatol; 2004; 22(5 Suppl 35):S77-82. PubMed ID: 15552519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
    Bergstra SA; Sepriano A; Kerschbaumer A; van der Heijde D; Caporali R; Edwards CJ; Verschueren P; de Souza S; Pope JE; Takeuchi T; Hyrich KL; Winthrop KL; Aletaha D; Stamm TA; Schoones JW; Smolen JS; Landewé RBM
    Ann Rheum Dis; 2023 Jan; 82(1):81-94. PubMed ID: 36410794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?
    Yagiz B; Coskun BN; Pehlivan Y; Dalkilic E; Kiraz S; Yazisiz V; Kucuksahin O; Erden A; Kanitez NA; Kimyon G; Emmungil H; Bilge SY; Kasifoglu T; Bes C; Bolek EC; Bilgin E; Karatas A; Kelesoglu B; Ersozlu D; Gonullu EO; Mercan R; Yilmaz S; Karadag O; Akar S; Ertenli I; Kalyoncu U
    Rheumatol Int; 2021 Nov; 41(11):1915-1924. PubMed ID: 34226947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dose of only 5 mg prednisolone daily retards radiographic progression in early rheumatoid arthritis - the Low-Dose Prednisolone Trial.
    Wassenberg S; Rau R; Zeidler H;
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S68-72. PubMed ID: 22018187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What do we know about the safety of corticosteroids in rheumatoid arthritis?
    Ethgen O; de Lemos Esteves F; Bruyere O; Reginster JY
    Curr Med Res Opin; 2013 Sep; 29(9):1147-60. PubMed ID: 23790244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids in rheumatoid arthritis: lessons from the Utrecht study.
    Jacobs JW; Bijlsma JW
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S59-62. PubMed ID: 22018185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glucocorticoid therapy in rheumatoid arthritis - pro].
    Pongratz G
    Dtsch Med Wochenschr; 2016 Oct; 141(22):1650. PubMed ID: 27824423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis.
    Cutolo M; Spies CM; Buttgereit F; Paolino S; Pizzorni C
    Arthritis Res Ther; 2014 Nov; 16 Suppl 2(Suppl 2):S1. PubMed ID: 25608624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuing versus tapering low-dose glucocorticoids in patients with rheumatoid arthritis and systemic lupus erythematosus in states of low disease activity or remission: A systematic review and meta-analysis of randomised trials.
    Palmowski A; Pankow A; Terziyska K; Nielsen SM; Christensen R; Bliddal H; Boyadzhieva Z; Buttgereit F
    Semin Arthritis Rheum; 2024 Feb; 64():152349. PubMed ID: 38100900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.